Stock analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research note issued on Wednesday. The firm set a “hold” rating on the stock.
Milestone Scientific Price Performance
Shares of NYSE MLSS opened at $0.98 on Wednesday. The business has a fifty day moving average price of $0.83 and a two-hundred day moving average price of $0.72. The stock has a market capitalization of $75.69 million, a PE ratio of -9.80 and a beta of 0.88. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.25.
Milestone Scientific (NYSE:MLSS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. The company had revenue of $2.25 million during the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
- Five stocks we like better than Milestone Scientific
- What is Short Interest? How to Use It
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- How to Effectively Use the MarketBeat Ratings Screener
- Jeff Brown’s Exegesis AI Stock Picks
- Stock Market Upgrades: What Are They?
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
